1Knight CD, Griffen FD. An improved technique for low anterior resection of the rectum using EEA stapler. Surgery., 1980,88:710- 714.
2FU CG, Muto T, Masaki T. Results of the double stapling procedure in colorectal surgery. Jpn J Surg, 1997,27:706-709.
3Heald R J, Moran B J, Ryall RD, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg, 1998,133:894-899.
4Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg, 1983,70:150-154.
5Tjandra JJ, Kilkenny JW, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum, 2005,48:411-423.
6Guillem JG, Chessin DB, Shia J, et al. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg, 2007,245:88-93.
7Maunsell HW. A new method of excising the lwo upper portions of the rectum and the lower segment of the sigmoid flexure of the colon. Lancet, 1892,2 : 473-476.
8Babcock WW. Experience with resection of the colon and the elimination of colostomy. Am J Surg, 1939, 46 : 186-203.
9Parks AG. Transanal technique in low rectal anastomoses. Proc R Soc Med, 1972,65:975-976.
4Gwyn K,Sinicrepe FA. Chemoprevention of colorectal cancer[J]. Am J Gastroenterel,2002,97(1) ： 13-21.
5Ruffinengo O, Tanno F, Covernton J, et al. Coloreetal cancer : epi- demiologic characteristics in a hospital center of Rosario,Argenti- na[J]. Acta Gastroenterol Latinoam,2010,40(2) :98-104.
6American Cancer Society. Coloreetal Cancer Facts & Figures 2011 -2013[ R]. Atlanta: American Cancer Society, 2011.
7Li CG, Huang X E, Xu L, et al. Clinical application of serum tumor associated material(TAM) from Non -small cell lung Cancer patients[ J]. Asian Pac J Cancer Prey, 2012, 13 (1) : 301 -304.
8Yang L, Chen X, Li Y, et al. Declines in serum CYFRA21 - 1 and carcinoembryonic antigen as predictors of chemotherapy re- sponse and survival in patients with advanced non - small cell lung Cancer[J]. Exp Ther Med, 2012, 4(2) : 243 -248.
9Edelman MJ, Hodgson L, Rosenblatt PY, et al. CYFRA 21 -1 as a prognostic and predictive marker in advanced non - small - cell lung Cancer in a prospective trial: CALGB 150304 [ J]. J Thorac Oncol, 2012, 7(4) : 649 -654.
10Hashimoto J, Ogawa K, Bai J, et al. Simultaneous dual - isotope imaging based on an artificial neural network for evaluating myocar- dial perfusion and fatty acid metabolism[J]. J Nucl Cardiol, 2013, 20(3) : 396 -405.
